PI departure from institution

The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from participating sleep clinics will be randomly exposed to either the individually tailored or standard OSA messages. Investigators will look at an effective and scalable intervention to improve OSA-related outcomes: a) clinical CVD and brain health measures and b) patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap, enabling real-time application of data-driven decision rules while implementing the intervention.

Inclusion Criteria:

• Self-reported race/ethnicity as African American, African, Caribbean or black
• Accessible by phone
• No plans to move away within the year
• OSA diagnosis, consent, including permission to release medical data
• Physician-diagnosed medical conditions.

Exclusion Criteria:

• Progressive illnesses in which disability or death is expected within 1 year
• Impaired cognitive/ functional ability precluding participation
• Intention to move within the same year of enrollment
• Family member currently enrolled

All of the individual participant data collected during the trial, after deidentification.

Beginning 3 months and ending 5 years following article publication.

Requests should be directed to Ferdinand.Zizi@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.